Lemaitre Vascular (LMAT) Misses Q3 EPS by 3c; Offers FY22 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts LMAT Hot Sheet
Price: $88.06 +9.26%
EPS Growth %: +11.3%
Financial Fact:
Foreign currency gain (loss): -61K
Today's EPS Names:
ATS, SICP, FTCO, More
EPS Growth %: +11.3%
Financial Fact:
Foreign currency gain (loss): -61K
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Lemaitre Vascular (NASDAQ: LMAT) reported Q3 EPS of $0.25, $0.03 worse than the analyst estimate of $0.28. Revenue for the quarter came in at $39 million versus the consensus estimate of $40.06 million.
GUIDANCE:
Lemaitre Vascular sees FY2022 EPS of $1.02-$1.08, versus the consensus of $1.09. Lemaitre Vascular sees FY2022 revenue of $160.5-162.9 million, versus the consensus of $163.6 million.
For earnings history and earnings-related data on Lemaitre Vascular (LMAT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HubSpot (HUBS) Tops Q3 EPS by 54c; offers guidance
- Allegiant Travel (ALGT) Tops Q3 EPS by 45c ; Offers Guidance
- Agilon Health Inc. (AGL) Tops Q3 EPS by 319c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
